The low levels of NAT2 catalytic activity observed in the NAT2_5 and NAT2_14 variants are in agreement with the kinetic profile obtained for NAT2_6-mediated APA acetylation11 and suggest that tumor cells retaining these variants after undergoing LOH would have comparable sensitivity levels towards APA treatment. This evidence concerns the gene NAT2 and neoplasm.